Matthew D Helm - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

Matthew D Helm

Showing results (11-20 of 13) with videos related to

Pageof 2

Sort By:

You have reached the last page of results.This site can display upto 13 results.

Nature Chemical Biology|December 5, 2017

Discovery and characterization of highly potent and selective allosteric USP7 inhibitorsGerald Gavory, Colin R O'Dowd, Matthew D Helm, et al.

ACS Medicinal Chemistry Letters|March 16, 2018

Identification and Structure-Guided Development of Pyrimidinone Based USP7 InhibitorsColin R O'Dowd, Matthew D Helm, J S Shane Rountree, et al.

Clinical and Translational Medicine|April 11, 2024

USP7 inhibitors suppress tumour neoangiogenesis and promote synergy with immune checkpoint inhibitors by downregulating fibroblast VEGFAnamarija Jurisic, Pei-Ju Sung, Mark Wappett, et al.

Pageof 2

Search research articles

Showing results (11-20 of 13) with videos related to

Sort By:

Pageof 2

You have reached the last page of results.This site can display upto 13 results.

Nature Chemical Biology|December 5, 2017

Discovery and characterization of highly potent and selective allosteric USP7 inhibitorsGerald Gavory, Colin R O'Dowd, Matthew D Helm, et al.

ACS Medicinal Chemistry Letters|March 16, 2018

Identification and Structure-Guided Development of Pyrimidinone Based USP7 InhibitorsColin R O'Dowd, Matthew D Helm, J S Shane Rountree, et al.

Clinical and Translational Medicine|April 11, 2024

USP7 inhibitors suppress tumour neoangiogenesis and promote synergy with immune checkpoint inhibitors by downregulating fibroblast VEGFAnamarija Jurisic, Pei-Ju Sung, Mark Wappett, et al.

Pageof 2